Immunopathologic Features of Retinal Lesions in Multiple Sclerosis (Q34605611)

3 August 2017

Immunopathologic Features of Retinal Lesions in Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

9 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

9 November 2022

author name string

M. J. Lucarelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724792

9 November 2022

J. S. Pepose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724792

9 November 2022

A. C. Arnold

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724792

9 November 2022

R. Y. Foos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724792

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1724792

9 November 2022

publication date

1 November 1991

1 reference

full work available at URL

3 August 2017

https://api.elsevier.com/content/article/PII:S0161642091320803?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

https://api.elsevier.com/content/article/PII:S0161642091320803?httpAccept=text/xml

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

9 November 2022

1 reference

3 August 2017

98

1 reference

3 August 2017

11

1 reference

3 August 2017

1652-1656

1 reference

Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Biochemical findings in multiple sclerosis. V. Transformation of lymphocytes from patients with multiple sclerosis by human basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Cellular hypersensitivity in attacks of multiple sclerosis: 1. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Protein Composition of Multiple Sclerosis Myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

The immunogenesis of the multiple sclerosis plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Immunofluorescence study of brain plaques from two patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Uveitis, perivenous sheathing and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

A system for the macroexamination of eyes in the laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Monoclonal antibodies against three major glycoproteins of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Periphlebitis retinae in multiple sclerosis. A histopathological study of two cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Chronic periphlebitis retinae in multiple sclerosis. A histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Optic neuropathy in multiple sclerosis; optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis in the faroe islands: I. Clinical and epidemiological features

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis and viruses: An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Declining incidence of multiple sclerosis in the Orkney Islands

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis: an immunologic reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Immunopathology of demyelination in autoimmune diseases and virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Multiple sclerosis: evidence for immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Myelin-associated glycoprotein in human retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

A shared antigenic determinant between natural killer cells and nervous tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Vasculo-occlusive retinopathy in experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Cancer-associated retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932080-3

7 January 2021

Sheathing of the retinal veins in multiple sclerosis

14

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

The ocular manifestations of disseminated sclerosis

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor

9 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease

9 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations

9 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32080-3

9 November 2022

Identifiers

1 reference

release_mlkehft7rbh5dnjwkjmqdsgqea

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mlkehft7rbh5dnjwkjmqdsgqea

24 November 2022

mapped directly with Wikidata item

1 reference